Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study ; volume:17 ; number:1 ; day:4 ; month:12 ; year:2017 ; pages:1-7 ; date:12.2017
BMC cancer ; 17, Heft 1 (4.12.2017), 1-7, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Iizumi, Sakura
- Contributor
-
Shimoi, Tatsunori
Tsushita, Natsuko
Bun, Seiko
Shimomura, Akihiko
Noguchi, Emi
Kodaira, Makoto
Yunokawa, Mayu
Yonemori, Kan
Shimizu, Chikako
Fujiwara, Yasuhiro
Tamura, Kenji
SpringerLink (Online service)
- DOI
-
10.1186/s12885-017-3846-8
- URN
-
urn:nbn:de:1111-201802036548
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Iizumi, Sakura
- Shimoi, Tatsunori
- Tsushita, Natsuko
- Bun, Seiko
- Shimomura, Akihiko
- Noguchi, Emi
- Kodaira, Makoto
- Yunokawa, Mayu
- Yonemori, Kan
- Shimizu, Chikako
- Fujiwara, Yasuhiro
- Tamura, Kenji
- SpringerLink (Online service)
Other Objects (12)
Do Eligibility Criteria Influence Unemployment?
Candidacy Eligibility Criteria and Party Unity
Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Anatomic Repair of Congenitally Corrected Transposition: Reappraisal of Eligibility Criteria
Eribulin drug review
Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer
A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer
Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
Eligibility criteria in clinical trials in breast cancer: a cohort study
Do Eligibility Criteria Influence Unemployment?
Candidacy Eligibility Criteria and Party Unity
Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Anatomic Repair of Congenitally Corrected Transposition: Reappraisal of Eligibility Criteria
Eribulin drug review
Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer
A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer
Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
Eligibility criteria in clinical trials in breast cancer: a cohort study
Do Eligibility Criteria Influence Unemployment?
Candidacy Eligibility Criteria and Party Unity
Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
Safety and effectiveness of eribulin in Japanese patients with locally advanced or metastatic breast cancer: a post-marketing observational study
A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma
Anatomic Repair of Congenitally Corrected Transposition: Reappraisal of Eligibility Criteria
Eribulin drug review
Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer
A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer
Eribulin in pretreated metastatic breast cancer patients: results of the TROTTER trial—a multicenter retrospective study of eribulin in real life
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer